カテゴリ： GlobalData, フランス, 企業調査

bioMerieux SA (BIM)-医療機器分野：企業M&A・提携分析

◆英語タイトル：bioMerieux SA (BIM) - Medical Equipment - Deals and Alliances Profile
◆商品コード：DATA8012946
◆発行会社（調査会社）：GlobalData
◆発行日：2017年11月27日
◆ページ数：92
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：フランス
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single UserUSD250 ⇒換算￥37,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD500 ⇒換算￥74,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
bioMerieux S.A. (bioMerieux) designs, develops and manufactures diagnostic systems and reagents for physicians and biologists. The company offers diagnostic solutions such as instruments, reagents and software. bioMerieux products are used diagnosing and managing infectious diseases, cardiovascular diseases and targeted cancers. The company also provides solutions for the enumeration of microbial flora, detection of specific pathogenic bacteria, monitoring of air and surface quality and sterility testing for agri-food, cosmetics and pharmaceutical industries. The company conducts its operations through subsidiaries and a broad network of distributors. bioMerieux is a part of the Institut Merieux group and is headquartered in Marcy l’Etoile, France.

bioMerieux SA (BIM) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
bioMerieux SA, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
bioMerieux SA, Medical Equipment Deals By Type, 2011 to YTD 2017 7
bioMerieux SA, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
bioMerieux SA, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
bioMerieux SA, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
bioMerieux SA, Medical Equipment, Deal Details 12
Venture Financing 12
Quanterix Raises US$19 Million In Series C Financing 12
Private Equity 14
BioTheranostics Raises USD32 Million in Private Equity Financing 14
Athyrium Opportunities Fund Invests US$20 Million In BioFire Diagnostics 15
Partnerships 16
Quanterix Enters into Licensing Agreement with bioMerieux 16
BioMerieux Enters into Licensing Agreement with Astute Medical 17
Seegene Enters Into Licensing Agreement With BioMerieux For DPO And TOCE Technologies 18
Lonza Walkersville Enters Into Licensing Agreement With Hyglos For Endotoxin Detection Patents 19
bioMerieux Enters Into Licensing Agreement With Quanterix For Simoa Technology 20
Biomerieux Enters into Agreement with Banyan Biomarkers 21
ITL Biomedical Enters into Distribution Agreement with bioMerieux Canada 22
Biotheranostics Enters into Agreement with Syapse 23
BioMerieux Enters into Co-Development Agreement with Copan Italia 24
BioMerieux Enters into Distribution Agreement with Copan 25
BioMerieux Enters into Distribution Agreement with Copan for WASP and WASPLab 26
BioMerieux Enters into Co-Development Agreement with Illumina 27
PathoGenetix And Applied Maths Enter Into Technology Integration Agreement For Pathogen Strain Typing 28
OpGen Enters Into Agreement With Applied Maths To Develop Whole Genome Mapping Software 29
Thermo Fisher Scientific Extends Co-Development Agreement With bioMerieux For Procalcitonin Testing 30
Debt Offering 31
bioMerieux Completes Private Placement Of Bonds Due 2020 For US$406.6 Million 31
Acquisition 32
bioMerieux to Acquire 34% Stake in Sysmex bioMerieux from Sysmex 32
BioMerieux Acquires Applied Maths 33
BioMerieux Completes Acquisition Of BioFire Diagnostics For US$486 Million 34
Biosynex Acquires Dima Gesellschaft Fur Diagnostika, Rapid Diagnostic Tests Maker 36
bioMerieux Completes Acquisition Of AES Laboratoire 37
bioMerieux Acquires Argene 39
bioMerieux SA – Key Competitors 40
bioMerieux SA – Key Employees 41
bioMerieux SA – Locations And Subsidiaries 43
Head Office 43
Other Locations & Subsidiaries 43
Recent Developments 48
Financial Announcements 48
Aug 30, 2017: bioMerieux – First-Half 2017 Results 48
Jul 20, 2017: bioMerieux – Second-Quarter 2017 Business Review 51
Apr 20, 2017: bioMerieux – First-Quarter 2017 Business Review 53
Mar 01, 2017: bioMerieux – 2016 Financial Results 56
Jan 19, 2017: bioMerieux – Fourth-Quarter 2016 Business Review 59
Oct 20, 2016: bioMerieux-Business Review for the nine months ended September 30, 2016 61
Aug 31, 2016: bioMerieux – First-Half 2016 Results 64
Jul 18, 2016: bioMerieux – Second-Quarter 2016 Business Review 68
Apr 20, 2016: bioMérieux – First-Quarter 2016 Business Review 71
Mar 02, 2016: bioMerieux – 2015 Financial Results 73
Jan 21, 2016: bioMerieux – Fourth-Quarter 2015 Business Review 77
Corporate Communications 80
Nov 07, 2016: Pierre Boulud appointed Corporate Vice Presidentof the Asia Pacific region at bioMerieux 80
Product News 81
Jan 05, 2017: Quanterix to Present at The 35th Annual J.P. Morgan Healthcare Conference 81
Oct 10, 2016: bioMerieux: Lyme disease diagnostic tests 82
Oct 06, 2016: bioMerieux introduces EviSight Compact, a new automated diagnostic solution for microbial detection in pharmaceutical productio 83
Jul 06, 2016: bioMerieux enlarges its pathogen identification capability on VITEK MS 84
Other Significant Developments 85
Oct 18, 2017: bioMerieux – Business review for the nine months ended September 30, 2017 85
Oct 10, 2016: BIOASTER, bioMerieux, ESPCI, GSK, Hospices Civils de Lyon and Sanofi join forces against sepsis 87
Aug 08, 2016: ITL contract extended with bioMerieux 89
May 31, 2016: bioMerieux and the Lyon Civil Hospitals strengthen their collaboration and expand their partnership to include Claude Bernard University Lyon 1 90
Mar 22, 2016: bioMérieux and COPAN announce the first commercial success of their collaboration for the automation and efficiency of microbiology laboratories 91
Appendix 92
Methodology 92
About GlobalData 92
Contact Us 92
Disclaimer 92

List of Tables
bioMerieux SA, Medical Equipment, Key Facts, 2016 2
bioMerieux SA, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
bioMerieux SA, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
bioMerieux SA, Medical Equipment Deals By Type, 2011 to YTD 2017 7
bioMerieux SA, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
bioMerieux SA, Deals By Market, 2011 to YTD 2017 9
bioMerieux SA, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Quanterix Raises US$19 Million In Series C Financing 12
BioTheranostics Raises USD32 Million in Private Equity Financing 14
Athyrium Opportunities Fund Invests US$20 Million In BioFire Diagnostics 15
Quanterix Enters into Licensing Agreement with bioMerieux 16
BioMerieux Enters into Licensing Agreement with Astute Medical 17
Seegene Enters Into Licensing Agreement With BioMerieux For DPO And TOCE Technologies 18
Lonza Walkersville Enters Into Licensing Agreement With Hyglos For Endotoxin Detection Patents 19
bioMerieux Enters Into Licensing Agreement With Quanterix For Simoa Technology 20
Biomerieux Enters into Agreement with Banyan Biomarkers 21
ITL Biomedical Enters into Distribution Agreement with bioMerieux Canada 22
Biotheranostics Enters into Agreement with Syapse 23
BioMerieux Enters into Co-Development Agreement with Copan Italia 24
BioMerieux Enters into Distribution Agreement with Copan 25
BioMerieux Enters into Distribution Agreement with Copan for WASP and WASPLab 26
BioMerieux Enters into Co-Development Agreement with Illumina 27
PathoGenetix And Applied Maths Enter Into Technology Integration Agreement For Pathogen Strain Typing 28
OpGen Enters Into Agreement With Applied Maths To Develop Whole Genome Mapping Software 29
Thermo Fisher Scientific Extends Co-Development Agreement With bioMerieux For Procalcitonin Testing 30
bioMerieux Completes Private Placement Of Bonds Due 2020 For US$406.6 Million 31
bioMerieux to Acquire 34% Stake in Sysmex bioMerieux from Sysmex 32
BioMerieux Acquires Applied Maths 33
BioMerieux Completes Acquisition Of BioFire Diagnostics For US$486 Million 34
Biosynex Acquires Dima Gesellschaft Fur Diagnostika, Rapid Diagnostic Tests Maker 36
bioMerieux Completes Acquisition Of AES Laboratoire 37
bioMerieux Acquires Argene 39
bioMerieux SA, Key Competitors 40
bioMerieux SA, Key Employees 41
bioMerieux SA, Other Locations 43
bioMerieux SA, Subsidiaries 43

★海外企業調査レポート[bioMerieux SA (BIM)-医療機器分野：企業M&A・提携分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • LGC Ltd-製薬・医療分野：企業M&A・提携分析
    Summary LGC Ltd (LGC) formerly LGC (Teddington) Limited, is a life sciences measurement and testing company which offers reference materials, genomics solutions and analytical testing products and services. Its products portfolio includes AutoGen, DNA extraction instrumentation, DNA extraction kits, …
  • STRATA Skin Sciences Inc (SSKN)：医療機器：M&Aディール及び事業提携情報
    Summary STRATA Skin Sciences Inc (STRATA) is a seller of therapeutic and aesthetic dermatology products. Its product portfolio comprises XTRAC laser and VTRAC excimer lamp; the STRATAPEN MicroSystems; and Nordlys. XTRAC laser and VTRAC excimer lamp systems are utilized for the treatment of psoriasis …
  • Green Plains Inc.：企業のM&A・事業提携・投資動向
    Green Plains Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Green Plains Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Binx Health Inc：企業の製品パイプライン分析
    Summary Binx Health Inc (Binx Health), a subsidiary of Binx Health Ltd, is a provider of near-patient and point of care (POC) testing solutions for women’s health. The company develops its proprietary, desktop, PCR-based point-of-care molecular diagnostic platform for diagnosis and treatment for chl …
  • Roper Technologies Inc (ROP)：企業の財務・戦略的SWOT分析
    Roper Technologies Inc (ROP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Packaging Corporation of America：企業の戦略・SWOT・財務分析
    Packaging Corporation of America - Strategy, SWOT and Corporate Finance Report Summary Packaging Corporation of America - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Falco SD Holdings Co Ltd (4671)：企業の財務・戦略的SWOT分析
    Summary Falco SD Holdings Co Ltd (Falco), formerly Falco Biosystems Ltd is a clinical testing and dispensing pharmacy service provider. The company offers services such as genetic testing, clinical trials, medical information systems development, and food sanitation and environmental testing. It pro …
  • Manulife (International) Limited：企業の戦略・SWOT・財務情報
    Manulife (International) Limited - Strategy, SWOT and Corporate Finance Report Summary Manulife (International) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Kwang Dong Pharmaceutical Co Ltd (009290)：製薬・医療：M&Aディール及び事業提携情報
    Summary Kwang Dong Pharmaceutical Co Ltd (Kwang Dong) is a drug manufacturer that develops, manufactures and supplies pharmaceuticals, health drinks and supplements. The company’s pharmaceutical products comprise OTC drugs, ETC drugs, general supplements, OTC drinks, consumer drinks, functional drin …
  • Laboratorios SALVAT SA-製薬・医療分野：企業M&A・提携分析
    Summary Laboratorios SALVAT SA (SALVAT) is a manufacturer of pharmaceutical products for healthcare industries. The company offers prescription and over-the- counter drugs in various segments such as personal healthcare, metabolism, urology, ophtholmology, dermatology and malaria. Its personal healt …
  • Compumedics Ltd (CMP)：企業の財務・戦略的SWOT分析
    Summary Compumedics Ltd (Compumedics) is a medical device company that develops and commercializes computer-based medical products. The company designs, develops and commercializes computer aided medical diagnostic systems. It provides product categories such as sleep diagnostics, neurology diagnost …
  • Illumina Inc (ILMN)：企業の財務・戦略的SWOT分析
    Illumina Inc (ILMN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Continental AG：企業のM&A・事業提携・投資動向
    Continental AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Continental AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Bank Sinopac：企業の戦略・SWOT・財務分析
    Bank Sinopac - Strategy, SWOT and Corporate Finance Report Summary Bank Sinopac - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • WIV Wein International AG：企業の戦略・SWOT・財務情報
    WIV Wein International AG - Strategy, SWOT and Corporate Finance Report Summary WIV Wein International AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Macquarie Telecom Group Limited (MAQ)：企業の財務・戦略的SWOT分析
    Macquarie Telecom Group Limited (MAQ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Goldin Properties Holdings Ltd：企業の戦略・SWOT・財務分析
    Goldin Properties Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Goldin Properties Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Daewoong Pharmaceutical Co Ltd (069620) – Product Pipeline Analysis, 2018 Uate
    Summary Daewoong Pharmaceutical Co Ltd (Daewoong Pharma) is one of the leading manufacturers and distributors of prescription drugs in South Korea. It offers prescription drugs, quasi drugs, medical devices, cosmetics, health foods and APIs. The company produces products in the forms of tablets, cap …
  • Verax Biomedical Inc-製薬・医療分野：企業M&A・提携分析
    Summary Verax Biomedical Inc (Verax) is a medical device company that develops rapid tests for the detection of bacterial contaminants in tissues for transplantation, blood components, and cellular therapies. The company’s products comprise platelet pgd test, red cell pgd test and cell therapy PGD t …
  • Exchange Income Corporation：企業の戦略・SWOT・財務分析
    Exchange Income Corporation - Strategy, SWOT and Corporate Finance Report Summary Exchange Income Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆